Showing results (61-70 of 228) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2007
Platelets take up the monoclonal antibody bevacizumabHenk M W Verheul, Martijn P J Lolkema, David Z Qian, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2023
The safety risk of information overload and bureaucracy in oncology clinical trial conductStefan G van Ravensteijn, Mirte Meijerink, Renée Nijenhuis-van Schayk, et al.
The Oncologist|January 14, 2015
Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiformeMyra E van Linde, Joost J C Verhoeff, Dirk J Richel, et al.
Clinical Genitourinary Cancer|August 8, 2017
Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal CarcinomaMadelon Q Wentink, Henk M W Verheul, Sumanta K Pal, et al.
Journal of Proteomics|April 6, 2015
Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell linesSander R Piersma, Jaco C Knol, Inge de Reus, et al.
Cancer Medicine|July 9, 2017
Identification of patients with cancer with a high risk to develop deliriumElisabeth C W Neefjes, Maurice J D L van der Vorst, Bertha A T T Verdegaal, et al.
Annals of Surgical Oncology|October 19, 2022
Locoregionally Recurrent Colon Cancer: How Far Have We Come? A Population-Based, Retrospective Cohort StudyHidde Swartjes, Daan W P van Lankveld, Felice N van Erning, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 27, 2010
[Non-metastasized oesophageal cancer]Surya S A Y Biere, Stijn J B van Weyenberg, Henk M W Verheul, et al.
Cancers|March 8, 2020
The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic ReviewCyrillo G Brahm, Myra E van Linde, Roelien H Enting, et al.
Pageof 23